Advertisement
Advertisement
BNTC
Benitec Biopharma Inc. Common Stock
10.49
USDSponsored
-0.32
-2.96%
Mar 27, 11:16 UTC -4
Open
BNTC Earnings Reports
Positive Surprise Ratio
BNTC beat 8 of 20 last estimates.
40%
Next Report
Date of Next Report
May 12, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.28
Implied change from Q2 26 (Revenue/ EPS)
--
/+7.69%
Implied change from Q3 25 (Revenue/ EPS)
--
/+16.67%
Benitec Biopharma Inc. Common Stock earnings per share and revenue
On Feb 12, 2026, BNTC reported earnings of -0.26 USD per share (EPS) for Q2 26, missing the estimate of -0.22 USD, resulting in a -14.14% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.66% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 8 analysts forecast an EPS of -0.28 USD, with revenue projected to reach -- USD, implying an increase of 7.69% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
Acumen Pharmaceuticals, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.46
Actual
-$0.41
Surprise
+11.29%
Spero Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.20
Actual
$0.53
Surprise
+359.80%
Rani Therapeutics Holdings, Inc. Class A Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.07
Surprise
-2.94%
Alpha Cognition Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.30
Surprise
-8.93%
Cognition Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.02
Surprise
+76.47%
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
Report Date
Mar 26, 2026 For Q4 25
Estimate
-Actual
-$0.71
Surprise
-
CollPlant Biotechnologies Ltd Ordinary Shares
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.67
Surprise
-245.72%
FAQ
What were Benitec Biopharma Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Benitec Biopharma Inc. Common Stock reported EPS of -$0.26, missing estimates by -14.14%, and revenue of $0.00, 0% as expectations.
How did the market react to Benitec Biopharma Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -2.66%, changed from $11.65 before the earnings release to $11.34 the day after.
When is Benitec Biopharma Inc. Common Stock expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for Benitec Biopharma Inc. Common Stock's next earnings report?
Based on 8
analysts, Benitec Biopharma Inc. Common Stock is expected to report EPS of -$0.28 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement